Tech Company Financing Transactions
Antheia Funding Round
Antheia secured a $40 million funding round on 6/23/2022. Investors included Oxford Finance and Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
6/23/2022
Transaction Type
Debt
Amount
$40,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will support Antheia's expansion with a 14,700 square-foot pilot plant located next to Antheia's headquarters in Menlo Park, Cal.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1430 O'Brien Dr. A
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Antheia combines founding intellectual property with world-leading expertise in synthetic biology, informatics, and fermentation technology to provide a stable and cost-competitive supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christina Smolke
Chief Scientific Officer
Kristy Hawkins
VP - Bus. Development
Yen-Hsiang Wang
Browse more venture capital transactions:
Prev: 6/23/2022: Sanas venture capital transaction
Next: 6/23/2022: JobGet venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs